ATE226450T1 - Gepufferte orthoesterpolymere enthaltende arzneimittel - Google Patents

Gepufferte orthoesterpolymere enthaltende arzneimittel

Info

Publication number
ATE226450T1
ATE226450T1 AT97906128T AT97906128T ATE226450T1 AT E226450 T1 ATE226450 T1 AT E226450T1 AT 97906128 T AT97906128 T AT 97906128T AT 97906128 T AT97906128 T AT 97906128T AT E226450 T1 ATE226450 T1 AT E226450T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
containing buffered
acid
orthoester
Prior art date
Application number
AT97906128T
Other languages
English (en)
Inventor
Robert Gurny
Monia Zignani
Cyrus Tabatabay
Original Assignee
Robert Gurny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Gurny filed Critical Robert Gurny
Application granted granted Critical
Publication of ATE226450T1 publication Critical patent/ATE226450T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AT97906128T 1996-03-05 1997-02-26 Gepufferte orthoesterpolymere enthaltende arzneimittel ATE226450T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96103391 1996-03-05
PCT/EP1997/000906 WO1997032606A1 (en) 1996-03-05 1997-02-26 Pharmaceutical compositions containing buffered ortho ester polymers

Publications (1)

Publication Number Publication Date
ATE226450T1 true ATE226450T1 (de) 2002-11-15

Family

ID=8222532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97906128T ATE226450T1 (de) 1996-03-05 1997-02-26 Gepufferte orthoesterpolymere enthaltende arzneimittel

Country Status (11)

Country Link
US (1) US6440460B1 (de)
EP (1) EP0885014B1 (de)
JP (1) JP4225570B2 (de)
KR (1) KR100441821B1 (de)
AT (1) ATE226450T1 (de)
AU (1) AU722303C (de)
DE (1) DE69716586T2 (de)
DK (1) DK0885014T3 (de)
ES (1) ES2185911T3 (de)
PT (1) PT885014E (de)
WO (1) WO1997032606A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040790A1 (en) 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US20020099438A1 (en) * 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US7168489B2 (en) * 2001-06-11 2007-01-30 Halliburton Energy Services, Inc. Orthoester compositions and methods for reducing the viscosified treatment fluids
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
US7569214B2 (en) 2002-09-09 2009-08-04 Nektar Therapeutics Al, Corporation Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
US7497278B2 (en) 2003-08-14 2009-03-03 Halliburton Energy Services, Inc. Methods of degrading filter cakes in a subterranean formation
US7691381B2 (en) * 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
WO2006096251A2 (en) 2005-03-03 2006-09-14 Icon Medical Corp. Improved metal alloys for medical device
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US20060200048A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Removable sheath for device protection
JP5411703B2 (ja) * 2006-11-09 2014-02-12 アルコン リサーチ， リミテッド 薬物送達のための水不溶性ポリマーマトリクス
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
BR112016030273A8 (pt) 2014-06-24 2021-05-18 Icon Medical Corp dispositivo médico e método para formar o referido dispositivo
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4010196A (en) * 1975-06-25 1977-03-01 American Home Products Corporation Linear polyester salts
US4268643A (en) * 1979-10-25 1981-05-19 Societa Italiana Resine S.I.R. S.P.A. Process for improving the stability of acetal polymers
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
DE3168032D1 (en) * 1980-11-10 1985-02-14 Alza Corp Erodible polymer containing erosion rate modifier
DE3642662A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Parenterale depotzubereitungen von regulatorischen peptiden enthaltend calciumacetat-glycerin-addukt, verfahren zu ihrer herstellung sowie die verwendung des addukts
EP0489843A4 (en) 1989-08-28 1992-08-12 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
AU2261592A (en) 1991-06-20 1993-01-25 Pharmaceutical Delivery Systems, Inc. Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents

Also Published As

Publication number Publication date
KR100441821B1 (ko) 2004-10-15
JP2000506148A (ja) 2000-05-23
KR19990087477A (ko) 1999-12-27
DE69716586D1 (de) 2002-11-28
ES2185911T3 (es) 2003-05-01
EP0885014B1 (de) 2002-10-23
US6440460B1 (en) 2002-08-27
AU722303C (en) 2001-12-06
JP4225570B2 (ja) 2009-02-18
WO1997032606A1 (en) 1997-09-12
DK0885014T3 (da) 2003-02-24
AU2093497A (en) 1997-09-22
EP0885014A1 (de) 1998-12-23
DE69716586T2 (de) 2003-07-17
AU722303B2 (en) 2000-07-27
PT885014E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
DE69716586D1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
AU8009998A (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
DK0874642T3 (da) Lægemiddelformuleringer med forhalet frigørelse
WO1999007351A3 (en) Indole derivatives and their use as mcp-1 antagonists
IL143063A0 (en) Cross-linked hyaluronic acids and medical uses thereof
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
NO2011009I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
AU1227899A (en) Osmotic medicament releasing system
MY117109A (en) Injectable quinolone formulations.
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
IS4996A (is) Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
SE9902742D0 (sv) New pharmaceutical formultion
CA2243988A1 (en) Pharmaceutical compositions containing buffered ortho ester polymers
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
ATE269693T1 (de) Abführmittel und verfahren zu deren herstellung
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0885014

Country of ref document: EP

REN Ceased due to non-payment of the annual fee